title: Drug pipeline: 1Q13.
authors.forename: Laura
authors.initials: L
authors.lastname: DeFrancesco
mesh_terms: D000080044:Ado-Trastuzumab Emtansine; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D017277:Drug Approval; D004921:Erythropoietin / Q000627:therapeutic use; D006801:Humans; D008453:Maytansine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D051297:Sodium-Glucose Transporter 2 / Q000627:therapeutic use; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D000068878:Trastuzumab; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D004921:Erythropoietin; D008453:Maytansine; D000068878:Trastuzumab; D000080044:Ado-Trastuzumab Emtansine